Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Achyut Healthcare standalone net profit declines 50.00% in the March 2026 quarter
Sales rise 377.17% to Rs 4.39 crore
Tata Elxsi launches AI tool to help healthcare firms get medical software approved faster
Tata Elxsi has launched AnaTel, an AI-native software development platform for healthcare and medical technology companies, co-developed with OpenAna.
Govt health spending triples to Rs 3.85 lakh crore in 2022-23: National Health Accounts
Government spending on healthcare has surged to Rs 3.85 lakh crore in 2022-23, nearly tripling from a decade ago. This increased public investment has led to a substantial drop in household out-of-pocket expenses for treatment. The share of government health spending in GDP has also risen. This indicates a positive shift towards more affordable and accessible healthcare for all citizens.
Entero Healthcare Gets Target Price Hike On Strong Q4 Earnings As Jefferies Eyes 17% Upside
Jefferies said Entero's medtech segment is expected to cross Rs 10 billion in FY27 as the business has better margins
Stocks to buy in 2026 for long term: Suzlon, Fortis Healthcare among 5 stocks that could give 10-60% returns
We have collated a list of recommendations from top brokerage firms from ETNow and other sources.
Himalaya Wealth launches ₹500 crore SME fund to back manufacturing, deeptech firms
The Category I AIF will target profitable growth-stage SMEs in sectors including aerospace, defence, industrial automation and healthcare, amid rising investor interest in manufacturing-led businesses.
Others open their wallets for buybacks. Cognizant turned to credit.
In Nasdaq filings last week, the US-headquartered IT services giant said it will draw $1 billion for the buyback from a $1.85 billion revolving credit facility. Cognizant had secured the credit line in 2014 to support the $2.7 billion acquisition of Trizetto, a healthcare-focused IT firm.
Blue Jet Healthcare jumps as Q4 PAT jumps 60% QoQ
Blue Jet Healthcare surged 6.26% to Rs 511.55 after the company reported strong sequential improvement in quarterly earnings.
Blue Jet Healthcare Shares Rally 6% On Strong Q4
This is a welcome rally for a stock that has fallen 37% over the last 12 months and is down 3% on a year-to-date basis. The positive momentum was largely driven by strong sequential performance in Q4.
Blue Jet Healthcare gains 8% post Q4; analysts split on near-term prospects
Emkay Global has retained its 'Reduce' rating, while Motilal Oswal has maintained its 'Buy' stance, reflecting contrasting expectations on recovery in key business segments and the margin trajectory
Stocks to buy: Sagar Doshi suggests Bandhan Bank, Metropolis Healthcare, CESC shares to buy - Mint
Stocks to buy: Sagar Doshi suggests Bandhan Bank, Metropolis Healthcare, CESC shares to buyMint
Healthcare, engineering and specialty chemicals remain key market themes: Mayuresh Joshi
Mayuresh Joshi, Director Research at Marketsmith India, believes execution will remain key for companies like Suzlon, while healthcare, engineering and select speciality chemical names continue to offer strong growth opportunities. He also sees India-focused engineering and capital goods companies remaining resilient despite global uncertainties. Joshi says investors should stay selective in IT, remains positive on Navin Fluorine, and is closely tracking niche AI-linked opportunities emerging in smaller tech firms.